Citation Impact
Citing Papers
Review of the current state of whole slide imaging in pathology
2011 Standout
Survival Effect of Maximal Cytoreductive Surgery for Advanced Ovarian Carcinoma During the Platinum Era: A Meta-Analysis
2002 Standout
Primary chemotherapy versus primary surgery for newly diagnosed advanced ovarian cancer (CHORUS): an open-label, randomised, controlled, non-inferiority trial
2015 Standout
Reasons for Improved Survival From Ovarian Cancer in New South Wales, Australia, Between 1980 and 2003
2009
Intracavitary chemotherapy with thiotepa in malignant pericardial effusions: an active and well-tolerated regimen.
1998
A Population-Based Study of Patterns of Care for Ovarian Cancer: Who Is Seen by a Gynecologic Oncologist and Who Is Not?
2002
The interferons: a biological system with therapeutic potential in viral infections
1994
Cross talk of signals between EGFR and IL-6R through JAK2/STAT3 mediate epithelial–mesenchymal transition in ovarian carcinomas
2008
Hepatocellular carcinoma
2016 Standout
Use of an indirect pharmacodynamic stimulation model of MX protein induction to compare in vivo activity of interferon alfa-2a and a polyethylene glycol-modified derivative in healthy subjects
1996
Ovarian cancer
2014 Standout
Timing of debulking surgery in advanced ovarian cancer
2008
Tumor-Derived G-CSF Facilitates Neoplastic Growth through a Granulocytic Myeloid-Derived Suppressor Cell-Dependent Mechanism
2011
Role of surgical outcome as prognostic factor in advanced epithelial ovarian cancer: A combined exploratory analysis of 3 prospectively randomized phase 3 multicenter trials
2009 Standout
Smoldering and polarized inflammation in the initiation and promotion of malignant disease
2005 Standout
CDDO-Me, a synthetic triterpenoid, inhibits expression of IL-6 and Stat3 phosphorylation in multi-drug resistant ovarian cancer cells
2008
Understanding the tumor immune microenvironment (TIME) for effective therapy
2018 Standout
Triterpenoids as new promising anticancer drugs
2009 Standout
Pancreatic cancer
2016 Standout
Molecular mechanisms of resistance and toxicity associated with platinating agents
2006 Standout
Obesity and inflammation: the linking mechanism and the complications
2016 Standout
The 2–5 A system: Modulation of viral and cellular processes through acceleration of RNA degradation
1998
Pattern of care and impact of participation in clinical studies on the outcome in ovarian cancer
2005
New insights into the mechanisms of epithelial–mesenchymal transition and implications for cancer
2018 Standout
Roles of the Raf/MEK/ERK pathway in cell growth, malignant transformation and drug resistance
2006 Standout
Specialist gynaecologists and survival outcome in ovarian cancer: a Scottish national study of 1866 patients
1999
Prospective Randomized Trials on Cytoreduction in Ovarian Cancer
1995
JAK/STAT, Raf/MEK/ERK, PI3K/Akt and BCR-ABL in cell cycle progression and leukemogenesis
2004
Evidence for a Causal Association Between Human Papillomavirus and a Subset of Head and Neck Cancers
2000 Standout
Diagnostic open laparoscopy in the management of advanced ovarian cancer
2005
Tissue and serum CA125 expression in endometrial cancer
2002
Predicting the Outcome of Cytoreductive Surgery for Advanced Ovarian Cancer: A Review
2010
Primary surgery for ovarian cancer
2006
Intraoperative tumor-specific fluorescence imaging in ovarian cancer by folate receptor-α targeting: first in-human results
2011 Standout
Evaluation of Preoperative Computed Tomography in Estimating Peritoneal Cancer Index in Colorectal Peritoneal Carcinomatosis
2008 Standout
The Relationship Between the Interferon α Response and Viral Burden in Primary SIV Infection
1996 StandoutNobel
Oncostatin M promotes bone formation independently of resorption when signaling through leukemia inhibitory factor receptor in mice
2010
The influence of the operating surgeon's specialisation on patient survival in ovarian carcinoma
1994
Gynecologic oncology group trials of chemotherapy for metastatic and recurrent cervical cancer
2005
Surgery and postoperative radiotherapy versus surgery alone for patients with stage-1 endometrial carcinoma: multicentre randomised trial
2000 Standout
p53Mutations and Presence of HPV DNA Do Not Correlate with Radiosensitivity of Gynecological Cancer Cell Lines
1998
Cytoreductive surgery for advanced stages of ovarian cancer
2000
Role of laparoscopy to evaluate candidates for complete cytoreduction in advanced stages of epithelial ovarian cancer
2006
Platinum-based neoadjuvant chemotherapy and interval surgical cytoreduction for advanced ovarian cancer: A meta-analysis
2006
IL-6 and related cytokines as the critical lynchpins between inflammation and cancer
2014
Variations in institutional infrastructure, physician specialization and experience, and outcome in ovarian cancer: A systematic review
2008
Ovarian Frozen Section Diagnosis: Use of Whole-Slide Imaging Shows Excellent Correlation Between Virtual Slide and Original Interpretations in a Large Series of Cases
2010
Stress signaling from the lumen of the endoplasmic reticulum: coordination of gene transcriptional and translational controls
1999 Standout
Neoadjuvant Chemotherapy or Primary Debulking Surgery in Advanced Ovarian Carcinoma: A Retrospective Analysis of 285 Patients
1998
Neutrophils in cancer: neutral no more
2016 Standout
Revisiting STAT3 signalling in cancer: new and unexpected biological functions
2014 Standout
Cancer-related inflammation and treatment effectiveness
2014 Standout
Endometrial cancer
1997
Port-site metastases after open laparoscopy: a study in 173 patients with advanced ovarian carcinoma
2005
Neoadjuvant Chemotherapy or Primary Surgery in Stage IIIC or IV Ovarian Cancer
2010 Standout
Protein therapeutics: a summary and pharmacological classification
2007 Standout
Tumor markers in patients with pancreatic carcinoma
1996
The role of IL-6 and STAT3 in inflammation and cancer
2005 Standout
Cancer-related inflammation, the seventh hallmark of cancer: links to genetic instability
2009 Standout
The Nature of Myeloid-Derived Suppressor Cells in the Tumor Microenvironment
2016 Standout
NF-κB, inflammation, immunity and cancer: coming of age
2018 Standout
Inflammatory bone loss: pathogenesis and therapeutic intervention
2012 Standout
Role of laparoscopy to assess the chance of optimal cytoreductive surgery in advanced ovarian cancer: a pilot study
2004
Delaying the primary surgical effort for advanced ovarian cancer: A systematic review of neoadjuvant chemotherapy and interval cytoreduction
2006
Predictors of comprehensive surgical treatment in patients with ovarian cancer
2007
Binding of Ovarian Cancer Antigen CA125/MUC16 to Mesothelin Mediates Cell Adhesion
2004 Standout
Treatment of Malignant Pericardial Effusion
1994
More than a sidekick: the IL-6 family cytokine IL-11 links inflammation to cancer
2010
Peginterferon Alfa-2a plus Ribavirin for Chronic Hepatitis C Virus Infection
2002 Standout
Guidelines on the Diagnosis and Management of Pericardial Diseases Executive SummaryThe Task Force on the Diagnosis and Management of Pericardial Diseases of the European Society of Cardiology
2004 Standout
Hemocyanin—a current perspective
1983
International Statistical Classification of Diseases and Related Health Problems
2014 Standout
Cooperative Autocrine and Paracrine Functions of Granulocyte Colony-Stimulating Factor and Granulocyte-Macrophage Colony-Stimulating Factor in the Progression of Skin Carcinoma Cells
2004
Role of Human Macrophage Polarization in Inflammation during Infectious Diseases
2018 Standout
Antiviral Actions of Interferons
2001 Standout
Macrophage Phenotypes Regulate Scar Formation and Chronic Wound Healing
2017 Standout
Impact of Adjuvant Chemotherapy and Surgical Staging in Early-Stage Ovarian Carcinoma: European Organisation for Research and Treatment of Cancer-Adjuvant ChemoTherapy in Ovarian Neoplasm Trial
2003
Specific inhibition of gene expression by small double-stranded RNAs in invertebrate and vertebrate systems
2001 StandoutNobel
Synthesis and crystal structure of a dinuclear rhodium complex. Catalytic activity of mono- and di-nuclear rhodium phosphite complexes in hydroformylation
1996 StandoutNobel
Intraperitoneal Cisplatin and Paclitaxel in Ovarian Cancer
2006 Standout
The interferons. Mechanisms of action and clinical applications
1991
Tumor-associated leukemia inhibitory factor and IL-6 skew monocyte differentiation into tumor-associated macrophage-like cells
2007
Endometrial Carcinoma
1996
Ovarian frozen section diagnosis: use of whole-slide imaging shows excellent correlation between virtual slide and original interpretations in a large series of cases.
2010
Works of Beth E. Nelson being referenced
A Phase II Trial of Isotretinoin and Alpha Interferon in Patients With Recurrent Squamous Cell Carcinoma of the Cervix
1998
Ovarian cancer staging: Does it require a gynecologic oncologist?
1992
Malignant pericardial effusion from squamous cell cancer of the cervix
1993
Primary radiation therapy for endometrial carcinoma: A case controlled study
1993
Interferons: Biological and clinical effects
1989
Accuracy of frozen-section (intraoperative consultation) diagnosis of ovarian tumors
1994
Coexpression of granulocyte colony stimulating factor and its receptor in primary ovarian carcinomas
2001
Preoperative abdominopelvic computed tomographic prediction of optimal cytoreduction in epithelial ovarian carcinoma.
1993
Interleukin-11 Receptor Expression in Primary Ovarian Carcinomas
2001
COEXPRESSION OF ONCOSTATIN M AND ITS RECEPTORS AND EVIDENCE FOR STAT3 ACTIVATION IN HUMAN OVARIAN CARCINOMAS
2002
Biological and clinical effects of the combination of beta- and gamma-interferons administered as a 5-day continuous infusion.
1990
Serial serum CA 125 measurements for evaluation of recurrence in patients with endometrial carcinoma.
1994
Terbium ion binding to Limuluspolyphemus hemocyanin
1981